| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2024 | NVCR Novocure Ltd | Scannell Timothy J | Director | Sell | 964 | $23.89 | $23,027.45 | -24.5% | -26.6% | -26.7% | |
| Jun 3, 2024 | RBOT Vicarious Surgical Inc. | Mazzola John71 | Chief Operating Officer | Sell | 6,854 | $0.32 | $2,202.88 | -2.2% | -40.1% | -26.2% | |
| Jun 3, 2024 | LUNG Pulmonx Corp | Lehman David Aaron79 | General Counsel | Sell | 5,475 | $6.97 | $38,160.75 | -0.6% | -5.8% | -53.9% | |
| Jun 3, 2024 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 7,167 | $0.32 | $2,303.47 | -0.6% | -40.1% | -26.2% | |
| Jun 3, 2024 | GKOS Glaukos Corp | Gilliam Joseph E55 | President &COO | Sell | 2,500 | $113.50 | $283,750.78 | -0.8% | +16.3% | -17.4% | |
| Jun 3, 2024 | TMDX Transmedics Group, Inc. | Khayal Tamer I53 | Chief Commercial Officer | Sell | 2,960 | $133.10 | $393,985.95 | -1.9% | +19.3% | -3.7% | |
| Jun 3, 2024 | ISRG Intuitive Surgical Inc | Barratt Craig H48 | Director | Sell | 2,496 | $402.89 | $1,005,613.44 | -100% | +19.7% | +36.6% | |
| Jun 3, 2024 | BSX Boston Scientific Corp | Carruthers Wendy | EVP, Human Resources | Sell | 6,983 | $75.33 | $526,029.39 | -13.3% | +7.5% | +36.6% | |
| Jun 3, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 6,144 | $1.02 | $6,266.88 | - | -14.8% | -39.0% | |
| Jun 3, 2024 | LUNG Pulmonx Corp | Rose Geoffrey Beran81 | Chief Commercial Officer | Sell | 4,297 | $6.97 | $29,950.09 | -0.4% | -5.8% | -53.9% | |
| Jun 3, 2024 | LIVN Livanova Plc | Moore Daniel Jeffrey82 | Director | Sell | 56,623 | $60.11 | $3,403,694.22 | -49.8% | -17.6% | -26.7% | |
| Jun 3, 2024 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | CEO | Sell | 13,896 | $0.32 | $4,468.95 | -0.8% | -40.1% | -26.2% | |
| Jun 3, 2024 | OM Outset Medical, Inc. | Grossman D Keith86 | Director | Sell | 38,117 | $3.78 | $144,233.88 | -23.8% | -86.2% | -66.1% | |
| Jun 3, 2024 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 2,060 | $135.93 | $280,015.80 | -8.8% | +19.3% | -3.7% | |
| Jun 3, 2024 | IRTC Irhythm Holdings, Inc. | Shrishrimal Sumi60 | EVP, Chief Risk Officer | Sell | 1,131 | $88.91 | $100,557.21 | -4.6% | -19.1% | +72.5% | |
| Jun 3, 2024 | CATX Perspective Therapeutics, Inc. | Woods Lori A70 | Director | Buy | 34,246 | $1.46 | $49,992.31 | +2.3% | +3.5% | -77.4% | |
| Jun 3, 2024 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 6,528 | $0.32 | $2,097.45 | -1.3% | -40.1% | -26.2% | |
| Jun 3, 2024 | IRMD Iradimed Corp | Allen Monty K46 | Director | Sell | 1,947 | $43.37 | $84,432.43 | -9.7% | +5.8% | +38.0% | |
| Jun 3, 2024 | PEN Penumbra Inc | Roberts Johanna54 | EVP, Gen. Counsel &Secretary | Sell | 600 | $188.90 | $113,338.61 | -0.2% | +9.0% | +36.9% | |
| Jun 3, 2024 | IRTC Irhythm Holdings, Inc. | Rosenbaum Marc W. | Chief Accounting Officer | Sell | 510 | $88.91 | $45,344.10 | -5.9% | -19.1% | +72.5% | |
| May 31, 2024 | DXCM Dexcom Inc | Brown Michael Jon72 | EVP Chief Legal Officer | Sell | 652 | $119.24 | $77,744.48 | -1.0% | -41.4% | -27.8% | |
| May 31, 2024 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Buy | 25,000 | $6.05 | $151,327.50 | +2.2% | +6.6% | -2.4% | |
| May 31, 2024 | ZBH Zimmer Biomet Holdings, Inc. | Yi Sang62 | Group President, Asia Pacific | Sell | 12,857 | $114.69 | $1,474,582.19 | -70.7% | -0.4% | -20.0% | |
| May 31, 2024 | CATX Perspective Therapeutics, Inc. | Williamson Robert F III63 | Director | Buy | 55,000 | $1.38 | $75,900.00 | +14.9% | +12.9% | -81.4% | |
| May 31, 2024 | CATX Perspective Therapeutics, Inc. | Hunt Jonathan Robert61 | Chief Financial Officer | Buy | 25,006 | $1.40 | $35,007.10 | +3.9% | +12.9% | -81.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.